Skip to main content
Clinical Trials/JPRN-UMIN000010492
JPRN-UMIN000010492
Completed
未知

Observational study for evaluation of effecacy and safety of ethinylestradiol therapy for postmenopausal hormone receptor-positive metastatic breast cancer patients heavily pre-treated with endocrine treatment - EE2 Observational Study

Study group for metastatic breast cancer0 sites65 target enrollmentApril 14, 2013
ConditionsBreast Cancer

Overview

Phase
未知
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Study group for metastatic breast cancer
Enrollment
65
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 14, 2013
End Date
October 31, 2015
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Study group for metastatic breast cancer

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. History of deep vain thrombosis, myocardial infarction and brain infarction 2\. Active double cancer, history of endometrial cancer and History of other cancer within 5 years (exclued in\-situ cervical cancer, basal cell carcinoma and squamous cell carcinoma of the skin) 3\. HER2\-positive breast cancer 4\. Bilateral breast cancer 5\. inflamatory breast cancer 6\. History of sever drug hypersensitivity 7\. pregnant or nursing female 8\. life\-threatening metastatic breast cancer 9\. The case which the family doctor judged to be unsuitable for the object of the study

Outcomes

Primary Outcomes

Not specified

Similar Trials